arcadia

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin
BSE763.25-7.85 (-1.02 %)
PREV CLOSE ( ) 771.10
OPEN PRICE ( ) 772.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 763.25 (47)
VOLUME 53290
TODAY'S LOW / HIGH ( )761.00 773.55
52 WK LOW / HIGH ( )723.55 986
NSE763.10-7.8 (-1.01 %)
PREV CLOSE( ) 770.90
OPEN PRICE ( ) 776.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 763.10 (60)
VOLUME 1382541
TODAY'S LOW / HIGH( ) 761.10 776.00
52 WK LOW / HIGH ( )723.65 986.1
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1983
Management Info
Manju D Gupta - Chairman Nilesh Deshbandhu Gupta - Managing Director
Registered Office

Address Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone 022 6640 2323

Email info@lupinworld.com

Website www.lupinworld.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
15Feb Lupin launches Clobazam Oral Suspension
Lupin has launched Clobazam Oral Suspension, 2.5mg/mL, having received a..
12Feb Lupin launches Tadalafil Tablets
Lupin has launched Tadalafil Tablets USP 20mg, having received an approv..
11Feb USFDA completes inspection of Lupin’s
United States Food and Drug Administration (USFDA) has completed inspect..
08Feb Lupin rises on getting approval from U
Lupin is currently trading at Rs. 831.00, up by 9.25 points or 1.13% fro..
07Feb Lupin gets approval from USFDA for Tad
Lupin has received approval for its Tadalafil tablets USP, 20 mg from th..
Financials
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit1418.213446.6
Gross Profit 3590.5 17939.3
Operating Profit 8195.622169.8
Net Sales 30928100881.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Fredun Pharma (BSE)
 361.90 (9.70%)
M.Cap ( in Cr)144.38
Themis Medicare (BSE)
 305.00 (8.73%)
M.Cap ( in Cr)280.02
Everest Organics (BSE)
 157.65 (16.86%)
M.Cap ( in Cr)126.12
Pfizer (BSE)
 2907.45 (0.58%)
M.Cap ( in Cr)13300.92
Jenburkt Pharma (BSE)
 474.90 (3.28%)
M.Cap ( in Cr)217.95
Shareholding Pattern
PROMOTERS 46.98%
NON-INSTITUTION 14.18%
MUTUAL FUNDS/UTI 5.69%
FI/BANKS/INSURANCE 5.38%
GOVERNMENT 0.27%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM